Remove 2027 Remove Health Insurance Remove Medicaid Remove Public Health
article thumbnail

Consumers and Cancer: 3 Patient-Focused Charts From IQVIA on the State of the Oncology in 2023

Jane Sarashon

Just in time for #ASCO2023, the IQVIA Institute published their annual report on Global Oncology Trends 2023 – Outlook to 2027 , an update featuring pipelines, therapy approvals, research updates, costs of oncology products, and patients. in 2023, and millions of more people worldwide.

article thumbnail

CMS Begins Option to Extend Medicaid Postpartum Coverage

Healthcare Law Blog

On April 1, 2022 , the Centers for Medicare & Medicaid Services (“CMS”) announced states may seek to extend Medicaid postpartum coverage from 60 days to one year through a new state plan option offered by the American Rescue Plan Act (“ARPA”). This option is available for five years and ends on March 31, 2027.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

Here’s why Grady Health System recognized as health care I.T. Million Health Care Fraud Conspiracy in Idaho Orthopedic activity in the 5 most underserved states St. for scholarships Yale New Haven investment leader departs DC D.C.’s

article thumbnail

National Health Spending Will Reach Nearly 20% of U.S. GDP By 2027

Health Populi

National health spending in the U.S. every year from 2020 to 2027, the actuaries at the Centers for Medicare and Medicaid Services forecast in their report, National Health Expenditure Projections, 2018-2927: Economic And Demographic Trends Drive Spending And Enrollment Growth , published yesterday by Health Affairs.

article thumbnail

Healthcare Reforms Under the IRA: Expanding Access to Care

Healthcare Law Blog

After 2026, the timing for publication is standardized – the February 1 st two years prior to the price applicability date will be the drug publication date. Fifteen more Part D drugs are set to be published in 2027, followed by 15 Part D and Part B drugs, collectively, in 2028. Negotiation-Eligible Drugs.